COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation

Machine learning (ML) algorithms were used to identify a novel biological target for breast cancer and explored its relationship with the tumor microenvironment (TME) and patient prognosis. The edgR package identified hub genes associated with overall survival (OS) and prognosis, which were validate...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Wenjie, Chen, Zhilin, Liu, Hui, Miao, Chen, Feng, Ruifa, Wang, Guilin, Chen, Guoping, Chen, Zhitong, Fan, Pingming, Pang, Weiyi, Li, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660229/
https://www.ncbi.nlm.nih.gov/pubmed/36389832
http://dx.doi.org/10.3389/fimmu.2022.937125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660229/
https://www.ncbi.nlm.nih.gov/pubmed/36389832
http://dx.doi.org/10.3389/fimmu.2022.937125

Ejemplares similares